WebINCB106385 will be tested either alone (monotherapy) or in combination with INCMGA00012. The purpose of this trial is to test the safety and tolerability of the monotherapy or combination therapy, find out what effects the study drugs have on people and their cancer, and to select the safe and tolerable dose of INCB106385 as … WebJun 17, 2024 · Known prior severe hypersensitivity to investigational product or any component in its formulations, including known severe hypersensitivity reactions to monoclonal antibodies (NCI CTCAE v 5 Grade ≥ 3) Patients who require concomitant use of medications that strongly induce or inhibit CYP3A (per section 15.0) Study Plan
Combination Margetuximab, INCMGA00012, MGD013, and …
WebOct 7, 2024 · • Patient dosing has begun in the Phase I/IIa study evaluating the anti-tumor effects of BriaCell’s lead candidate, Bria-IMT™ in combination with Incyte’s INCMGA00012 and epacadostat in patients with advanced breast cancer. • Cancer blocks the immune system preventing it from fighting and destroying cancer cells. Bria-IMT™ activates the … WebThe purpose of this study is to assess the effectiveness of INCMGA00012 in participants with locally advanced or metastatic squamous carcinoma of the anal canal (SCAC) who have progressed after platinum-based chemotherapy. Participation eligibility rc helicopter making
INCMGA00012 (PD-1 antibody) for Pancreatic Cancer
WebThe purpose of this study is to assess the clinical activity and safety of INCMGA00012 in participants with metastatic merkel cell carcinoma (MCC). Participation eligibility … WebA Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy Additional contact information Cancer-related trials contact form … WebA Phase 3 Global, Multicenter, Double-Blind Randomized Study of Carboplatin-Paclitaxel With INCMGA00012 or Placebo in Participants With Inoperable Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Anal Canal Not Previously Treated With Systemic Chemotherapy (POD1UM-303/InterAACT 2) IRAS ID 286160 Contact name Sheela Rao … rc helicopter night